DailyStocks Stock Article Search

https://seekingalpha.com/article/4534275-gossamer-bio-goss-investor-presentation-slideshow?source=feed_sector_healthcare Aug 14, 2022 - 0

https://www.zacks.com/stock/news/2209668/all-you-need-to-know-about-2seventy-bio-inc-tsvt-rating-upgrade-to-strong-buy?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2209668 Jan 12, 2024 - 2seventy bio, Inc. (TSVT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. 0

https://www.zacks.com/stock/news/2212223/sana-bio-sana-stock-rallies-105-in-3-months-here-s-why?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2212223 Jan 18, 2024 - Sana Bio (SANA) rallies 105% after the company reports encouraging pipeline progress with its candidates, SC291 and SC262, for oncology and autoimmune indications. 0

https://www.zacks.com/stock/news/2218877/2seventy-bio-tsvt-divests-r-d-assets-to-regeneron-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2218877 Jan 31, 2024 - 2seventy bio (TSVT) inks an asset purchase agreement with Regeneron to sell its oncology and autoimmune pipeline to the latter. 0

https://www.zacks.com/stock/news/2224777/is-adicet-bio-acet-outperforming-other-medical-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2224777 Feb 12, 2024 - Here is how Adicet Bio, Inc. (ACET) and Adma Biologics (ADMA) have performed compared to their sector so far this year. 0

https://www.zacks.com/stock/news/2233203/is-adicet-bio-acet-stock-outpacing-its-medical-peers-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2233203 Feb 28, 2024 - Here is how Adicet Bio, Inc. (ACET) and Adma Biologics (ADMA) have performed compared to their sector so far this year. 0

https://www.zacks.com/stock/news/2236964/generation-bio-co-gbio-reports-q4-loss-lags-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2236964 Mar 06, 2024 - Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -29.27% and 5.64%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2237343/should-you-buy-gossamer-bio-goss-after-golden-cross?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2237343 Mar 07, 2024 - Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average? 0

https://www.zacks.com/stock/news/2238205/nuvation-bio-inc-nuvb-is-up-25-28-in-one-week-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2238205 Mar 08, 2024 - Does Nuvation Bio Inc. (NUVB) have what it takes to be a top stock pick for momentum investors? Let's find out. 0

https://www.zacks.com/stock/news/2241353/are-medical-stocks-lagging-adicet-bio-acet-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2241353 Mar 15, 2024 - Here is how Adicet Bio, Inc. (ACET) and Adma Biologics (ADMA) have performed compared to their sector so far this year. 0